Astrazeneca Plc (AZN)
$77.11
Astrazeneca Plc (AZN) Share Price Forecast
Currently 37 wall-street analysts regularly analyze the financials of Astrazeneca Plc on a frequent basis to provide recommendations along with target share price. 37 analysts offering 12-month price forecasts for Astrazeneca Plc (AZN) have a share price target of $82.74. This median of share price forecast represents a 7.3% upside from the latest price of $77.11 as on 23.05.24.
Astrazeneca Plc (AZN) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Astrazeneca Plc (AZN) share price will touch around $82.74 in next 12-months.
Astrazeneca Plc (AZN) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Astrazeneca Plc's share price and its median forecast price. As on 23.05.24, the difference is -7.65%
Astrazeneca Plc (AZN): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Astrazeneca Plc (AZN) Share Price : Analyst Recommendation
Based on 37 analysts tracking and researching Astrazeneca Plc (AZN) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 20 | 20 | 20 |
| Outperform | 10 | 11 | 11 |
| Hold | 9 | 6 | 6 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
Astrazeneca Plc (AZN) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Astrazeneca Plc (AZN) is $82.74, offered by 37 analysts offering 12-month price forecasts.
Astrazeneca Plc (AZN) has a maximum of 0.07 upside potential, based on 37 analysts offering 12-month price forecasts.
Based on 37 analysts tracking and researching Astrazeneca Plc (AZN), 83.78% have a buy recommendation. Remaining 16.22% have either sell or hold recommendations.
The latest share price of Astrazeneca Plc (AZN) is $77.11 as of 23/05/2024.
31 of total 37 analysts offering stock ratings for Astrazeneca Plc AZN have recommended buy rating.
₹0 US Stocks a/c Opening Fee